Assessment of the safety and gut microbiota modulation ability of an infant formula containing Bifidobacterium animalis ssp. lactis CP-9 or Lactobacillus salivarius AP-32 and the effects of the formula on infant growth outcomes: insights from a four-
The trial was registered with the US Library of Medicine (clinicaltrials.gov) with the number NCT03993301 on 20/06/2019.
Authors
- Ching-Min Li
- Jia‐Hung Lin (ORCID: https://orcid.org/0000-0003-3386-6313)
- Yen-Yu Huang (ORCID: https://orcid.org/0000-0003-3661-1949)
- Ko-Chiang Hsia
- Shang‐Po Shen (ORCID: https://orcid.org/0000-0002-5647-8447)
- Yu-Chieh Hsu (ORCID: https://orcid.org/0000-0003-3714-4262)
- Jui‐Fen Chen
- Yi‐Wei Kuo (ORCID: https://orcid.org/0000-0001-5107-426X)
- Hung-Chih Lin
- Huishan Wang (ORCID: https://orcid.org/0000-0002-7372-3125)
- Hsieh‐Hsun Ho
- Shin‐Yu Tsai
Institutions
- Asia University (TW)
- China Medical University (TW)
- China Medical University Hospital (TW)
- GenMont Biotech (Taiwan) (TW)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1186/s12887-024-05289-7
- Citations
- 9
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 3.14